Microfluidic hemophilia models using blood from healthy donors
Abstract Background Microfluidic clotting assays permit drug action studies for hemophilia therapeutics under flow. However, limited availability of patient samples and Inter‐donor variability limit the application of such assays, especially with many patients on prophylaxis. Objective To develop ap...
Enregistré dans:
Auteurs principaux: | , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/71da544d77aa43e085358a8ca40dc390 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!